Preview

Medical Immunology (Russia)

Advanced search

THE ROLE OF THREE-LOCUS HLA HAPLOTYPES (HLA-DRB1-DQA1-DQB1) IN THE PATHOGENESIS OF ALLOIMMUNIZATION, ATOPY, AND VIRAL INFECTION

https://doi.org/10.15789/1563-0625-TRO-3307

Abstract

HLA alloimmunization, allergic rhinitis/atopic dermatitis, and tick-borne encephalitis serve as relevant models for investigating genetically determined immune responses to three types of antigens: alloantigens, allergens, and viral antigens. Previous research has primarily focused on individual HLA alleles, without considering haplotype-level interactions and potential synergistic effects among HLA genes. This study aimed to identify associations between three-locus HLA haplotypes (HLA-DRB1-DQA1-DQB1) and the risk of developing HLA alloimmunization, allergic rhinitis, atopic dermatitis, and tick-borne encephalitis. Twelve common European haplotypes were analyzed in 215 patients and 317 healthy controls. Alloimmunization risk was assessed in 61 recipients of blood components, atopic conditions were evaluated in 50 patients with persistent allergic rhinitis and atopic dermatitis, and the clinical course of tick-borne encephalitis was examined in 104 patients. Genotyping was performed using real-time PCR (DNA Technology, Russia) at the Laboratory of Immunohematology, Kirov Scientific Research Institute of Hematology and Blood Transfusion. Statistical analyses included chi-square. The haplotypes HLA-DRB104-DQA103:01-DQB1*03:02 and HLA-DRB103-DQA105:01-DQB1*02:01 were significantly associated with the development of HLA alloimmunization. Their complete overlap with genetic markers of autoimmune diseases suggests a shared mechanism by which HLA molecules mediate the presentation of both autoantigens and alloantigens. It has been shown that distinct HLA haplotypes are associated with specific clinical phenotypes of atopy. Specifically, HLA-DRB112-DQA105:01-DQB1*03:01 and HLA-DRB115-DQA101:02-DQB1*06:02 are linked to a selective predisposition toward respiratory sensitization, whereas HLA-DRB101-DQA101:01-DQB1*05:01 is associated with systemic atopy that includes a cutaneous component. These findings support the immunogenetic heterogeneity of atopic disorders, indicating that allergic rhinitis and atopic dermatitis are distinct endotypes within the broader “atopic continuum.” The analysis revealed that a prognostically favorable form of tick-borne encephalitis—the fever form, characterized by an intact humoral antiviral immune response—was found to be associated with the HLA-DRB109-DQA103:01-DQB1*03:03 haplotype. More severe forms involving central nervous system damage and dysfunction in both humoral and cellular immunity were linked to distinct haplotypes: the meningeal form was associated with HLA-DRB108-DQA104:01-DQB1*04:01/04:02, while the focal form correlated with HLA-DRB116-DQA101:02-DQB1*05:02/05:04. These findings have important implications for clinical practice, particularly in guiding patient stratification, forecasting disease progression, and informing the selection of targeted preventive and therapeutic strategies.

About the Authors

E. V. Butina
Osteosintez LLC, Kirov, Russian Federation
Russian Federation
MD, PhD, Dr. Sci. Med.


I. G. Suetina
FSBEI HE Kirov SMU MOH Russia, Kirov, Russian Federation
Russian Federation
MD, PhD, Cand. Sci. Med., associate Professor of the Department of Pediatrics


O. N. Lyubeznova
FSBEI HE Kirov SMU MOH Russia, Kirov, Russian Federation
Russian Federation
MD, PhD, Cand. Sci. Med., associate Professor of the Department of Infectious Diseases


References

1. Бондаренко А.Л., Контякова Е.Л., Тихомолова Е.Г., Зыкова И.В., Зянчурина Г.М.. Клинико-иммунологические прогностические критерии развития очаговых форм клешевого энцефалита // Медицинский альманах. – 2011. – T.18, №5. C. 228-231. Bondarenko A.L., Kontyakova E.L., Tikhomolova E.G., Zykova I.V., Zy-anchurina G.M. Clinical and immunological prognostic criteria for the development of focal forms of tick-borne encephalitis. Medical almanac. 2011; Vol. 18, no. 5, pp. 228-231. (in Russ.)

2. Бутина Е.В., Шерстнев Ф.С., Максимов О.Д., Зайцева Г.А., Попонина Е.А., Йовдий А.В., Парамонов И.В. Технические и организационные аспекты профилактики HLA-аллоиммунизации и рефрактерности к трансфузиям тромбоцитов у гематологических больных // Трансфузиология. – 2018. – T.19, №4. C. 59–66. Butina E.V., Sherstnev F.S., Maxi-mov O.D., Zaitseva G.A., Poponina E.A., Yovdiy A.V., Paramonov I.V. Technical and organizational aspects of prophylaxis of HLA-alloimmunization and platelet refrac-toriness in hematological patients. Transfusiology, 2018; Vol.19, no. 4, pp. 59-66. (in Russ.) https://transfusion-web.ru/f/4-2018.pdf

3. Бутина Е.В., Шерстнев Ф.С., Максимов О.Д., Йовдий А.В., Парамонов И.В. Роль генов HLA в развитии HLA-аллоиммунизации у реципиентов компонентов крови. // Клиническая лабораторная диагностика. – 2022. – T. 67, №5. C. 292-295. Butina E.V., Sherstnev F.S., Maksi-mov O.D., Yovdiy A.V., Paramonov I.V. Role of HLA genes in develop-ment of HLA-alloimmunization in blood recipients. Clinical laboratory diagnostics, 2022; Vol. 67, no. 5, pp. 292-295. (in Russ.) https://clinlabdia.ru/article/rol-genov-hla-v-razvitii-hla-alloimmunizacz/

4. Галанина А.В., Иллек Я.Ю., Рыбакова Т.Н., Рассанова Е.А., Суслова Е.В. Полиморфизм генов HLA и их связь с атопическим дерматитом // Российский вестник перинатологии и педиатрии. – 2022. – T.67, № 4. C. 213–214. Galanina A.V., Illek Ya.Yu., Rybako-va T.N., Rassanova E.A., Suslova E.V.. Polymorphism of HLA genes and their association with atopic dermatitis. Rossiyskiy vestnik perina-tologii i pediatrii, 2022, Vol. 67, no. 4, pp. 213-214. (in Russ.) https://doi.org/10.21508/1027-4065-congress-2022

5. Иллек Я.Ю., Суетина И.Г., Хлебникова Н.В., Суслова Е.В. HLA-ассоциации у детей с атопическими заболеваниями // Практика педиатра. – 2023. - №2. С. 60–63. Illek Ya.Yu., Suetina I.G., Khlebni-kova N.V., Suslova E.V. HLA-associations in children with atopic diseases. Pediatrician's Practice, 2023, Vol. 2, pp. 60–63. (In Russ.) https://medi.ru/pp/2023/03/28006/

6. Киселева А.Н., Бутина Е.В., Исаева Н.В., Зайцева Г.А., Поздеев Н.М., Овчинников В.В. Характер распределения антигенов системы HLA у супружеских пар с репродуктивными расстройствами // Акушерство, гинекология и репродукция. – 2019. – T.13, №2. C. 111-118. Kiseleva A.N., Butina E.V., Isaeva N.V., Zaitseva G.A., Pozdeev N.M., Ovchinnikov V.V. Distribution of antigens of the HLA-system in mar-ried couples with reproductive disor-ders. Obstetrics Gynecology and Re-production, 2019, Vol. 13, no. 2, pp. 111-118. (In Russ.)

7. https://doi.org/10.17749/2313-7347.2019.13.2.111-118

8. Лаптев Д.Н., Еремина И.А., Шубина Е.С.., Янкевич Т.Э., Сечко Е.А., Гончарова Н.А., Петеркова В.А. Аллельные варианты генов главного комплекса гистосовместимости у детей с сахарным диабетом 1 типа, заболевших в дошкольном возрасте // Сахарный диабет. – 2024. – T. 27, №4. C. 313–320. Laptev D.N., Eremina I.A., Shubina E.S. Shubina E.S., Yankevich T.E., Sechko E.A., Goncharova N.A., Pe-terkova V.A. Allelic variants of genes of the main histocompatibility com-plex in children with type 1 diabetes mellitus who became ill at preschool age. Diabetes mellitus, 2024, Vol. 27, no. 4, pp. 313-320. (In Russ.)

9. https://doi.org/10.14341/DM13101

10. Любезнова О.Н., Бондаренко А.Л. Клиническое значение определения генов HLA II типа (DRB1, DQA1 и DQB1) при клещевом энцефалите // Медицинская иммунология. 2025 – T.27, №2. C. 317–328. Lyubeznova O.N., Bondarenko A.L. Clinical significance of class II HLA genes (DRB1, DQA1 and DQB1) in tick-born encephalitis. Medical Im-munology (Russia), 2025, Vol. 27, no. 2, pp. 317-328. (In Russ.) https://doi.org/10.15789/1563-0625-SCO-3016

11. Суслова Е.В., Хлебникова Н.В., Суетина И.Г., Иллек Я.Ю. Иммуногенетические параметры при атопическом дерматите у детей разного возраста // Вятский медицинский вестник. – 2020. – T.68, №4. C. 8–11. Suslova E.V., Khlebnikova N.V., Suetina I.G., Illek Ya. Yu Immuno-genetic parameters in children of dif-ferent ages with atopic dermatitis. Medical newsletter of Vyatka, 2020, Vol. 68, no. 4, pp. 8-11. (In Russ.) doi:10.24411/2220-7880-2020-10121

12. Хамаганова Е.Г., Абдрахимова А.Р., Леонов Е.А., Хижинский С.П., Гапонова Т.В., Савченко В.Г. Секвенирование следующего поколения в HLA-типировании больных с показаниями к трансплантации аллогенных гемопоэтических стволовых клеток и их доноров // Гематология и трансфузиология. – 2021. – T. 66, №2. C. 206–217. Khamaganova E.G., Abdrakhimova A.R., Leonov E.A., Khizhinskiy S.P., Gaponova T.V., Savchenko V.G. Next generation sequencing HLA-typingof recipients and donors of allogeneic haematopoietic stem cells. Gematologiya i transfuziologi-ya = Russian Journal of Hematology and Transfusiology, 2021, Vol. 66, no. 2, pp. 206-217. (In Russ.)

13. https://doi.org/10.35754/0234-5730-2021-66-2-206-217

14. Хамаганова Е.Г., Хижинский С.П., Абдрахимова А.Р., Кузьминова Е.П., Леонов Е.А., Покровская О.С., Кузьмина Л.А., Паровичникова Е.Н. Мультилокусные HLA-гаплотипы (A-B-C-DRB1-DRB3/DRB4/DRB5-DQA1-DQB1-DPA1-DPB1) в семьях больных с назначением к трансплантации аллогенных гемопоэтических стволовых клеток // Медицинская иммунология. – 2024. T. 26, №2. C. 291-302. Khamaganova E.G., Khizhinskiy S.P., Abdrakhimova A.R., Kuzminova E.P., Leonov E.A., Pokrovskaya O.S., Kuzmina L.A., Parovichnikova E.N.Multilocus HLA haplotypes (A-B-C-DRB1-DRB3/DRB4/DRB5-DQA1-DQB1-DPA1-DPB1) in families of patients scheduled for allogeneic hematopoietic stem cell transplantation. Medical Immunology (Russia), 2024, Vol. 26, no. 2, pp. 291-302. (In Russ.) https://doi.org/10.15789/1563-0625-MHH-2651

15. Шамгунова Б.А., Попов Е.А., Левитан Б.Н. Ассоциация аллелей HLA-DRB1 И HLA-DQB1 с сезонным аллергическим ринитом и атопической (пыльцевой) бронхиальной астмой) // Фундаментальные исследования. – 2011. – T.11, №3. C. 578-581. Shamgunova B.A., Popov E.A., Levitan B.N. Association of HLA-DRB1 and HLA-DQB1 alleles with seasonal allergic rhinitis and atopic (pollen) bronchial asthma. Fundamental Research, 2011, Vol. 11, no. 3, pp. 578-581. (In Russ.)

16. https://fundamental-research.ru/ru/article/view?id=29277

17. Abels W.C., Celik A.A., Simper G.S., Blasczyk R., Bade-Döding C. Polypeptide - New Insight into Drug Discovery and Develop-ment. InTech; 2018. - http://dx.doi.org/10.5772/intechopen.76871

18. Agache I., Akdis C.A., Akdis M., Canonica G.W., Casale T., Chivato T., Corren J., Chu D.K., Del Giacco S., Eiwegger T., Flood B., Firinu D., Gern J.E., Hamelmann E., Hanania N., Hernández-Martín I., Knibb R., Mäkelä M., Nair P., O'Mahony L., Papadopoulos N.G., Papi A., Park H.S., Pérez de Llano L., Pfaar O., Quirce S., Sastre J., Shamji M., Schwarze J., Palomares O., Jutel M.. EAACI Biologicals Guidelines-Recommendations for severe asthma. Allergy, 2021, Vol. 76, no. 1, pp. 14-44. - doi: 10.1111/all.14425

19. Álvaro-Benito M., Morrison E., Ebner F, Abualrous E., Urbicht M., Wieczorek M. Distinct editing functions of natural HLA-DM allotypes impact antigen presenta-tion and CD4+ T cell activation. Cell. Mol. Immunol., 2020, Vol. 17, pp. 133–142. - https://doi.org/10.1038/s41423-018-0181-1

20. Anzurez A., Naka I., Miki S., Nakayama-Hosoya K., Isshiki M., Watanabe Y., Nakamura-Hoshi M., Seki S., Matsumura T., Takano T., Onodera T., Adachi Y., Moriyama S., Terahara K., Tachikawa N., Yoshimura Y., Sasaki H., Horiuchi H., Miyata N., Miyazaki K., Koga M., Ikeuchi K., Nagai H., Saito M., Adachi E., Yotsuyanagi H., Kutsuna S., Kawashima A., Miyazato Y., Kinoshita N., Kouno C., Tanaka K., Takahashi Y., Suzuki T., Matano T., Ohashi J., Kawana-Tachikawa A. Association of HLA-DRB1*09:01 with severe COVID-19. HLA, 2021, Vol. 98, no. 1, pp. 37-42. - doi: 10.1111/tan.14256

21. Blackwell J.M., Jamieson S.E., Burgner D. HLA and Infectious Diseases. Clin. Microbiol. Rev., 2009, 22. - https://doi.org/10.1128/cmr.00048-08

22. Bousquet J., Anto J.M., Wickman M.., Keil T, Valenta R., Haahtela T., Lodrup Carlsen K., van Hage M., Akdis C., Bachert C., Akdis M., Auffray C., Annesi-Maesano I., Bindslev-Jensen C., Cambon-Thomsen A., Carlsen K.H., Chatzi L., Forastiere F., Garcia-Aymerich J., Gehrig U., Guerra S., Heinrich J., Koppelman G.H., Kowalski M.L., Lambrecht B., Lupinek C., Maier D., Melén E., Momas I., Palkonen S., Pinart M., Postma D., Siroux V., Smit H.A., Sunyer J., Wright J., Zuberbier T., Arshad S.H., Nadif R., Thijs C., Andersson N., Asarnoj A., Ballardini N., Ballereau S., Bedbrook A., Benet M., Bergstrom A., Brunekreef B., Burte E., Calderon M., De Carlo G., Demoly P., Eller E., Fantini M.P., Hammad H., Hohman C., Just J., Kerkhof M., Kogevinas M., Kull I., Lau S., Lemonnier N., Mommers M., Nawijn M., Neubauer A., Oddie S., Pellet J., Pin I., Porta D., Saes Y., Skrindo I., Tischer C.G., Torrent M., von Hertzen L. Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal type 2 signalling? The MeDALL hypothesis. Allergy, 2015, Vol. 70, no. 9, pp. 1062-1078. - doi: 10.1111/all.12637

23. Bousquet J., Khaltaev N., Cruz A.A., Denburg J., Fokkens W.J., Togias A., Zuberbier T., Baena-Cagnani C.E., Canonica G.W., van Weel C., Agache I., Aït-Khaled N., Bachert C., Blaiss M.S., Bonini S., Boulet L.P., Bousquet P.J., Camargos P., Carlsen K.H., Chen Y., Custovic A., Dahl R., Demoly P., Douagui H., Durham S.R., van Wijk R.G., Kalayci O., Kaliner M.A., Kim Y.Y., Kowalski M.L., Kuna P., Le L.T., Lemiere C., Li J., Lockey R.F., Mavale-Manuel S., Meltzer E.O., Mohammad Y., Mullol J., Naclerio R., O'Hehir R.E., Ohta K., Ouedraogo S., Palkonen S., Papadopoulos N., Passalacqua G., Pawankar R., Popov T.A., Rabe K.F., Rosado-Pinto J., Scadding G.K., Simons F.E., Toskala E., Valovirta E., van Cauwenberge P., Wang D.Y., Wickman M., Yawn B.P., Yorgancioglu A., Yusuf O.M., Zar H., Annesi-Maesano I., Bateman E.D., Ben Kheder A., Boakye D.A., Bouchard J., Burney P., Busse W.W., Chan-Yeung M., Chavannes N.H., Chuchalin A., Dolen W.K., Emuzyte R., Grouse L., Humbert M., Jackson C., Johnston S.L., Keith P.K., Kemp J..P, Klossek J.M., Larenas-Linnemann D., Lipworth B., Malo J.L., Marshall G.D., Naspitz C., Nekam K., Niggemann B., Nizankowska-Mogilnicka E., Okamoto Y., Orru M.P., Potter P., Price D., Stoloff S.W., Vandenplas O., Viegi G., Williams D.; World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy, 2008, Vol. 63, Suppl. 86, pp. 8-160. - doi: 10.1111/j.1398-9995.2007.01620.x.

24. Bousquet J., Melén E., Haahtela T., Koppelman G.H., Togias A., Valenta R., Akdis C.A., Czarlewski W., Rothenberg M., Valiulis A., Wickman M., Akdis M., Aguilar D., Bedbrook A., Bindslev-Jensen C., Bosnic-Anticevich S., Boulet L.P., Brightling C.E., Brussino L., Burte E., Bustamante M., Canonica G.W., Cecchi L., Celedon J.C., Chaves Loureiro C., Costa E., Cruz A.A., Erhola M., Gemicioglu B., Fokkens W..J, Garcia-Aymerich J., Guerra S., Heinrich J., Ivancevich J.C., Keil T., Klimek L., Kuna P., Kupczyk M., Kvedariene V, Larenas-Linnemann D.E., Lemonnier N., Lodrup Carlsen K.C., Louis R., Makela M., Makris M., Maurer M., Momas I., Morais-Almeida M., Mullol J., Naclerio R.N., Nadeau K., Nadif R., Niedoszytko M., Okamoto Y., Ollert M., Papadopoulos N.G, Passalacqua G., Patella V.., Pawankar R, Pham-Thi N., Pfaar O., Regateiro F.S., Ring J., Rouadi P.W., Samolinski B., Sastre J., Savouré M., Scichilone N., Shamji M.H., Sheikh A., Siroux V., Sousa-Pinto B.., Standl M, Sunyer J., Taborda-Barata L., Toppila-Salmi S., Torres M.J., Tsiligianni I., Valovirta E., Vandenplas O., Ventura M.T., Weiss S., Yorgancioglu A., Zhang L., Abdul Latiff A.H., Aberer W., Agache I., Al-Ahmad M., Alobid I., Ansotegui I.J., Arshad S.H., Asayag E., Barbara C., Baharudin A., Battur L., Bennoor K..S, Berghea E..C, Bergmann K.C., Bernstein D., Bewick M., Blain H., Bonini M., Braido F., Buhl R., Bumbacea R.S., Bush A., Calderon M., Calvo-Gil M., Camargos P., Caraballo L., Cardona V., Carr W., Carreiro-Martins P., Casale T., Cepeda Sarabia A.M., Chandrasekharan R., Charpin D., Chen Y.Z., Cherrez-Ojeda I., Chivato T., Chkhartishvili E., Christoff G., Chu D.K., Cingi C., Correia de Sousa J., Corrigan C., Custovic A., D'Amato G., Del Giacco S., De Blay F.., Devillier P, Didier A., do Ceu Teixeira M., Dokic D., Douagui H, Doulaptsi M, Durham S., Dykewicz M., Eiwegger T., El-Sayed Z.A., Emuzyte R., Fiocchi A., Fyhrquist N., Gomez R.M., Gotua M., Guzman M.A., Hagemann J.., Hamamah S, Halken S., Halpin D.M.G., Hofmann M., Hossny E., Hrubiško M., Irani C., Ispayeva Z., Jares E., Jartti T., Jassem E., Julge K., Just J., Jutel M., Kaidashev I., Kalayci O., Kalyoncu A.F., Kardas P., Kirenga B., Kraxner H., Kull I., Kulus M., La Grutta S., Lau S., Le Tuyet Thi L., Levin M., Lipworth B., Lourenço O., Mahboub B., Martinez-Infante E., Matricardi P., Miculinic N., Migueres N., Mihaltan F., Mohammad Y., Moniuszko M., Montefort S., Neffen H., Nekam K., Nunes E., Nyembue Tshipukane D., O'Hehir R., Ogulur I., Ohta K., Okubo K., Ouedraogo S., Olze H., Pali-Schöll I., Palomares O., Palosuo K., Panaitescu C., Panzner P., Park H.S., Pitsios C., Plavec D., Popov T.A., Puggioni F., Quirce S., Recto M., Repka-Ramirez M.S., Robalo Cordeiro C., Roche N., Rodriguez-Gonzalez M., Romantowski J., Rosario Filho N., Rottem M., Sagara H., Serpa F.S., Sayah Z., Scheire S, Schmid-Grendelmeier P., Sisul J.C., Sole D., Soto-Martinez M., Sova M., Sperl A., Spranger O., Stelmach R., Suppli Ulrik C., Thomas M., To T., Todo-Bom A., Tomazic P.V., Urrutia-Pereira M., Valentin-Rostan M., Van Ganse E., van Hage M., Vasankari T., Vichyanond P., Viegi G., Wallace D., Wang D.Y., Williams S., Worm M., Yiallouros P., Yusuf O., Zaitoun F., Zernotti M., Zidarn M., Zuberbier J., Fonseca J.A., Zuberbier T., Anto J.M. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis. Allergy, 2023 Vol. 78, no.5, pp. 1169-1203. - doi: 10.1111/all.15679

25. Brandt D.YC., César J., Goudet J., Meyer D. The Effect of Bal-ancing Selection on Population Differentiation: A Study with HLA Genes. G3 (Bethesda), 2018, Vol. 8, no. 8, pp. 2805-2815. - doi: 10.1534/g3.118.200367

26. Brewerton D.A., Hart F.D., Nicholls A. Caffrey M., James D.C., Sturrock R.D. Ankylosing spondylitis and HL-A 27. Lancet, 1973, Vol.1(7809):904-907. - doi: 10.1016/s0140-6736(73)91360-3

27. Delves P.J. Human Leukocyte Antigen (HLA) System. MSD Professional Manual, 2024 - https://www.msdmanuals.com/professional/immunology-allergic-disorders/biology-of-the-immune-system/human-leukocyte-antigen-hla-system

28. Dendrou C,. Petersen J., Rossjohn J., Fugger L. HLA vari-ation and disease. Nat. Rev. Im-munol., 2018, Vol. 18, pp. 325–339. - https://doi.org/10.1038/nri.2017.143

29. Erlich H., Valdes A.M., Noble J., Carlson J.A., Varney M., Concannon P., Mychaleckyj J.C,. Todd J.A., Bonella P., Fear A.L.., Lavant E, Louey A., Moonsamy P. Type 1 Diabetes Genetics Consor-tium. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabe-tes genetics consortium families. Diabetes, 2008, Vol. 57, no. 4, pp.1084-1092. - doi: 10.2337/db07-1331

30. Flesch B.K., Matheis N., Alt T., Weinstock C., Bux J., Kahaly G. J. HLA Class II Haplotypes Dif-ferentiate Between the Adult Auto-immune Polyglandular Syndrome Types II and III. The Journal of Clinical Endocrinology & Metab-olism, 2014; Vol. 99, no. 1, pp. E177–E182. - https://doi.org/10.1210/jc.2013-2852

31. Gambino C..M, Aiello A., Accardi G., Caruso C., Candore G. Auto-immune diseases and 8.1 ancestral haplotype: An update. HLA, 2018, Vol. 92, no. 3, pp. 137-143. - doi: 10.1111/tan.13305

32. Gerritsma J.J., Oomen I., Meinderts S., van der Schoot C.E., Biemond B.J., van der Bom J.G., Fijnvandraat K. SCORE consortium. Back to base pairs: What is the genetic risk for red blood cell alloimmunization? Blood Rev., 202,; Vol.48, pp. 100794. - doi: 10.1016/j.blre.2020.100794

33. Gregersen P.K., Silver J., Win-chester R.J. The shared epitope hypothesis. An approach to un-derstanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum., 1987, Vol. 30, no. 11, pp. 1205-1213. - doi: 10.1002/art.1780301102

34. Ilonen J., Kiviniemi M., El-Amir M.I., Nygård L., Härkönen T., Lempainen J., Knip M. Finnish Pediatric Diabetes Register. In-creased Frequency of the HLA-DRB1*04:04-DQA1*03-DQB1*03:02 Haplotype Among HLA-DQB1*06:02-Positive Children With Type 1 Diabetes. Diabetes, 2024, Vol. 73, no. 2, pp. 306-311. - https://doi.org/10.2337/db23-0387

35. Kargar M., Kaydani G.A., Keikhaei B., Saki N., Jalalifar M.A. Association between HLA-DRB1*04, HLA-DQB1*03, and HLA-DQB1*06 with alloimmun-ization in transfusion-dependent patients with thalassemia: the first case-control study in Iran. Ann Hematol., 2025, Vol. 104, pp.1493–1499. - https://doi.org/10.1007/s00277-025-06288-z

36. Kovalchuka L., Eglite J., Zalite M. The frequency of HLA-DR alleles in patients with tick-borne disease from Latvia. Res. J. Infect. Dis., 2014, Vol. 2, 4. - doi: 10.7243/2052-5958-2-4

37. Megiorni F., Pizzuti A. HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing. J Biomed. Sci., 2012; Vol. 19, article number: 88. - https://doi.org/10.1186/1423-0127-19-88

38. MHC Haplotype Consortium Web Resource http://www.sanger.ac.uk/HGP/Chr6/MHC/

39. Muñiz-Castrillo S., Vogrig A., Honnorat J. Associations between HLA and autoimmune neurologi-cal diseases with autoantibodies. Autoimmun Highlights., 2020; Vol. 11, article number: 2. - https://doi.org/10.1186/s13317-019-0124-6

40. Natarajan K., Jiang J., May N.A., Mage M.G., Boyd L.F., McShan A.C. The Role of Molecular Flex-ibility in Antigen Presentation and T Cell Receptor-Mediated Signal-ing. Front. Immunol., 2018; Vol. 9. - https://doi.org/10.3389/fimmu.2018.01657

41. Oliveira L.C., Porta G., Marin M.L., Bittencourt P..L, Kalil J.., Goldberg AC. Autoimmune hepa-titis, HLA and extended haplo-types. Autoimmun Rev., 2011, Vol. 10, no. 4, pp.189-193. - doi: 10.1016/j.autrev.2010.09.024

42. Pinart M., Benet M.., Annesi-Maesano I, von Berg A., Berdel D., Carlsen K.C., Carlsen K.H., Bindslev-Jensen C., Eller E., Fantini M.P., Lenzi J., Gehring U.., Heinrich J., Hohmann C, Just J., Keil T.., Kerkhof M, Kogevinas M., Koletzko S., Koppelman G.H., Kull I.., Lau S, Melén E., Momas I., Porta D., Postma D.S., Rancière F., Smit H.A., Stein R.T., Tischer C.G., Torrent M., Wickman M., Wijga A.H., Bousquet J., Sunyer J., Basagaña X., Guerra S., Garcia-Aymerich J., Antó J.M. Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study. Lancet Respir. Med., 2014, Vol. 2, no. 2, pp. 131-40. - doi: 10.1016/S2213-2600(13)70277-7

43. Pugliese A., Boulware D., Yu L., Babu S., Steck A.K., Becker D., Rodriguez H., DiMeglio L., Ev-ans-Molina C., Harrison L.C., Schatz D., Palmer J.P.., Green-baum C, Eisenbarth G..S, Sosen-ko J.M. Type 1 Diabetes TrialNet Study Group. HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Through-out the Stages of Disease Pro-gression. Diabetes, 2016, Vol. 65, no.4, pp. 1109-19. - doi: 10.2337/db15-1105

44. Schonewille H., Doxiadis I., Lev-ering W., Roelen D.L., Claas F.H.J., Brand A. HLA-DRB1 as-sociations in individuals with sin-gle and multiple clinically relevant red blood cell antibodies. Transfu-sion, 2014 Vol. 54, np. 8, pp. 1971-80. - doi: 10.1111/trf.12624

45. Shirafkan F., Hensel L., Rattay K. Immune tolerance and the preven-tion of autoimmune diseases es-sentially depend on thymic tissue homeostasis. Front. Immunol., 2024, Vol. 15. - https://doi.org/10.3389/fimmu.2024.1339714

46. Soha A., Azina I., Rozentale B., Kramicha K., Sture G., Savicka O., Titovica G. HLA class II DRB1, DQA1, DQB1 loci in pa-tients with HIV infection and tu-berculosis in a Latvian cohort group. Cent. Eur. J. Immunol., 2024, Vol. 49, no. 1, pp. 37-44. - doi: 10.5114/ceji.2024.138738

47. Stasiak M., Stasiak B., Zawadzka-Starczewska K., Lewiński A. Sig-nificance of HLA in Graves’ dis-ease and Graves’ orbitopathy in Asian and Caucasian populations – a systematic review. Front. Im-munol., 2023, Vol. 14, pp. 1256922. - doi: 10.3389/fimmu.2023.1256922

48. Tian L., Hou L., Wang .L, Xu H., Xiao J., Ying B. HLA-DRB1*09:01 allele is associated with anti-E immunization in a Chinese population. Transfusion, 2018, Vol. 58, no. 6, pp. 1536-1539. - doi: 10.1111/trf.14568

49. Thorstenson Y.R., Creary L.E., Huang H., Rozot V., Nguyen T.T., Babrzadeh F., Kancharla S., Fu-kushima M., Kuehn R., Wang C., Li M., Krishnakumar S., Min-drinos M., Fernandez Vina M. A., Scriba T.J., Davis M.M. Allelic resolution NGS HLA typing of class I and class II loci and haplo-types in Cape Town, South Africa. Hum. Immunol. 2018, 79(12): 839-847. - https://doi.org/10.1016/j.humimm.2018.09.004

50. Van Lier R.A., ten Berge I.J., Gamadia L.E. Human CD8(+) T-cell differentiation in response to viruses. Nat. Rev. Immunol., 2003, Vol. 3, no. 12, pp. 931-939. - doi: 10.1038/nri1254

51. Verduin E.P., Brand A., van de Watering L.M., Roelen D.L., Kanhai H.H., Doxiadis I.I., Claas F.H., Schonewille H. The HLA-DRB1*15 phenotype is associated with multiple red blood cell and HLA antibody responsiveness. Transfusion, 2016, Vol. 56, no. 7, pp. 1849-1856. - doi: 10.1111/trf.13648

52. Waage J., Standl M., Curtin J.A et al. Genome-wide asso-ciation and HLA fine-mapping studies identify risk loci and genetic pathways un-derlying allergic rhinitis. Nat. Genet., 2018, Vol. 50, no. 8, pp. 1072-1080. - doi: 10.1038/s41588-018-0157-1

53. Weidinger S., Willis-Owen S.A., Kamatani Y., Baurecht H., Morar N., Liang L., Edser P., Street T., Rodriguez E., O'Regan G.M., Beattie P., Fölster-Holst R., Franke A., Novak N., Fahy C.M., Winge M.C., Kabesch M., Illig T., Heath S., Söderhäll C., Melén E., Pershagen G., Kere J., Bradley M., Lieden A., Nordenskjold M., Harper J.I., McLean W.H., Brown S.J., Cookson W.O., Lathrop G.M., Irvine A.D., Moffatt M.F. A genome-wide associa-tion study of atopic dermatitis identifies loci with overlap-ping effects on asthma and psoriasis. Hum. Mol. Genet,. 2013, Vol. 22, no. 23, pp. 4841-4856. - doi: 10.1093/hmg/ddt317

54. Zhang T., Li Y., Yuan X., Bao X., Chen L., Jiang X., He J. Estab-lishment of NGS-based HLA 9-locus haplotypes in the Eastern Han Chinese population high-lights the role of HLA-DP in do-nor selection for transplantation. HLA, 2022, Vol. 100, no. 6, pp. 582-596. - https://doi.org/10.1111/tan.14798


Supplementary files

1. Неозаглавлен
Subject
Type Other
Download (16KB)    
Indexing metadata ▾
2. Неозаглавлен
Subject
Type Other
Download (16KB)    
Indexing metadata ▾
3. Неозаглавлен
Subject
Type Other
Download (18KB)    
Indexing metadata ▾
4. Неозаглавлен
Subject
Type Other
Download (16KB)    
Indexing metadata ▾
5. Неозаглавлен
Subject
Type Other
Download (17KB)    
Indexing metadata ▾
6. Неозаглавлен
Subject
Type Other
Download (16KB)    
Indexing metadata ▾
7. Неозаглавлен
Subject
Type Other
Download (15KB)    
Indexing metadata ▾
8. 3307
Subject
Type Other
Download (55KB)    
Indexing metadata ▾

Review

For citations:


Butina E.V., Suetina I.G., Lyubeznova O.N. THE ROLE OF THREE-LOCUS HLA HAPLOTYPES (HLA-DRB1-DQA1-DQB1) IN THE PATHOGENESIS OF ALLOIMMUNIZATION, ATOPY, AND VIRAL INFECTION. Medical Immunology (Russia). (In Russ.) https://doi.org/10.15789/1563-0625-TRO-3307

Views: 130

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1563-0625 (Print)
ISSN 2313-741X (Online)